TRANSFORMATION OF HUMAN KERATINOCYTES IS CHARACTERIZED BY QUANTITATIVE AND QUALITATIVE ALTERATIONS OF THE T-16 ANTIGEN (TROP-2, MOV-16)

被引:6
作者
SCHON, MP [1 ]
ORFANOS, CE [1 ]
机构
[1] FREE UNIV BERLIN,MED CTR STEGLITZ,DEPT DERMATOL,W-1000 BERLIN,GERMANY
关键词
D O I
10.1002/ijc.2910600113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The regulation of synthesis and post-translational processing of the T-16 antigen, a human cell-surface glycoprotein of 50 to 60 kDa, was investigated in normal and transformed human keratinocytes in vitro. Normal keratinocytes of follicular origin were compared with squamous-cell-carcinoma lines, spontaneously immortalized keratinocytes, and SV-40 transformed keratinocytes. FAGS analysis and radioimmunoprecipitation showed that the synthesis and expression of T-16 was 3- to 4-fold higher in transformed keratinocytes than in their normal counterparts. In normal keratinocytes, no quantitative differences were observed among freshly prepared cells, primary cultures and sub-cultures. In SDS-PAGE, a single broad band at 50 to 60 kDa was observed in normal keratinocytes, whereas 2 bands at 42 and 45 to 55 kDa were detected after transformation. Tunicamycin treatment of living cells and glycosidase digestion of immunopurified T-16 antigen revealed this molecular heterogeneity to be due to different N-glycosylation in normal and transformed keratinocytes. In pulse-chase experiments, 2 distinct precursor proteins at 38 and 42 kDa were detected in transformed keratinocytes, whereas in normal cells the 38-kDa signal was dramatically decreased. These findings indicate that quantitative and qualitative changes of T-16 mark the transformation process of human keratinocytes, showing similar post-translational alterations in all transformed populations investigated. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 25 条
  • [1] ALBELDA SM, 1993, LAB INVEST, V68, P4
  • [2] BIOCHEMICAL-CHARACTERIZATION OF TROP-2, A CELL-SURFACE MOLECULE EXPRESSED BY HUMAN CARCINOMAS - FORMAL PROOF THAT THE MONOCLONAL ANTIBODY-T16 AND ANTIBODY-MOV-16 RECOGNIZE TROP-2
    ALBERTI, S
    MIOTTI, S
    STELLA, M
    KLEIN, CE
    FORNARO, M
    MENARD, S
    COLNAGHI, MI
    [J]. HYBRIDOMA, 1992, 11 (05): : 539 - 545
  • [3] ALBERTI S, 1991, European Journal of Cancer, V27, pS65, DOI 10.1016/0277-5379(91)91444-N
  • [4] ALBERTI S, 1993, J CELL BIOCHEM S, V17, P107
  • [5] BERNARD BA, 1985, CANCER RES, V45, P1707
  • [6] BLITHE DL, 1993, TRENDS GLYCOSCI GLYC, V5, P81
  • [7] NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE
    BOUKAMP, P
    PETRUSSEVSKA, RT
    BREITKREUTZ, D
    HORNUNG, J
    MARKHAM, A
    FUSENIG, NE
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 106 (03) : 761 - 771
  • [8] INITIAL EVALUATION OF A NEW EPITHELIAL ANTIGEN (T16) FOR BIVARIATE FLOW-CYTOMETRY OF BLADDER IRRIGATION SPECIMENS
    BRETTON, PR
    MYC, A
    CORDONCARDO, C
    DEANGELIS, P
    FAIR, WR
    MELAMED, MR
    [J]. CYTOMETRY, 1989, 10 (03): : 339 - 344
  • [9] MONOCLONAL-ANTIBODIES DETECT OCCULT BREAST-CARCINOMA METASTASES IN THE BONE-MARROW OF PATIENTS WITH EARLY STAGE DISEASE
    COTE, RJ
    ROSEN, PP
    HAKES, TB
    SEDIRA, M
    BAZINET, M
    KINNE, DW
    OLD, LJ
    OSBORNE, MP
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1988, 12 (05) : 333 - 340
  • [10] EISINGER M, 1979, P NATL ACAD SCI USA, V76, P5340, DOI 10.1073/pnas.76.10.5340